\
&
Contact us
\
&
Contact us
This was 1 year ago
LocationMaison Irène et Frédéric Joliot-Curie
This science conference, organised by the French Alternative Energies and Atomic Energy Commission (CEA), has as main objectives:
It starts off with speakers from CEA and the European Commission, the European Brain Council & European Brain Foundation, to continue with presentations of various (mainly French) research institutes regarding Neurodegenerative Diseases, Psychiatric Diseases and Neurotechnologies.
Details about the programme and registration can be found on the conference website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
